|
|
|
|
|
|
Sierra Oncology Inc (SRRA)
|
|
1.14 -0.03 (-2.56%)
|
6/26/2017 4:00pm
|
|
Open:
|
1.19
|
Pre. Close:
|
1.17
|
|
High:
|
1.22
|
Low:
|
1.14
|
|
Volume:
|
151,187
|
Market Cap:
|
59.59M
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
-
|
-
|
|
Low:
|
-
|
-
|
|
Close:
|
-
|
-
|
|
|
|
|
|
|
Technical analysis (as of: 2017-06-26 11:36:46 PM)
|
|
Overall:
|
 
|
|
Stoxline posted a SELL today, downgraded from higher rating. This stock seems to be ready for a new bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.
|
|
Target:
|
Six months: 1.46 One year: 1.57
|
|
Support:
|
Support1: 1.10 Support2: 0.92
|
|
Resistance:
|
Resistance1:
1.25 Resistance2: 1.34
|
|
Pivot:
|
1.18 
|
|
Moving Averages:
|
MA(5): 1.16 MA(20): 1.18
MA(100): 1.36 MA(250): 1.57
|
|
MACD:
|
MACD(12,26):
-0.03 Signal(12,26,9): -0.03
|
|
%K %D:
|
%K(14,3): 25.00 %D(3): 26.85
|
|
RSI:
|
RSI(14): 42.15
|
|
52-Week:
|
High: 2.25
Low: 1.10 Change(%): -42.1
|
|
Average Vol(K):
|
3-Month: 216
10-Days 255
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.SRRA has closed above bottom band by 25.7%. Bollinger Bands are 3.3% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
|
|
|
Headline News
|
|
Mon, 05 Jun 2017 11:44:12 GMT
Sierra Oncology shares jump 7.3% premarket on news of positive early-stage ...
Tue, 30 May 2017 11:03:47 GMT
Sierra Oncology Granted US and EU Patents for Chk1 inhibitor SRA737
Wed, 22 Feb 2017 16:18:45 GMT
With New Cash and Cancer Targets, Analyst Sees Almost 200% Upside in Sierra ...
Mon, 26 Jun 2017 15:37:10 GMT
Active Runner in Focus: Sierra Oncology Inc (SRRA)
Tue, 27 Jun 2017 02:37:30 GMT
Sierra Oncology Inc (SRRA): Inside the Numbers
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
NA
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
